Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia starts earlier in males than females, with different treatments, and is linked to income, education, alcohol use, and mental health.

In post-menopausal women, signs of increased male hormones should be checked for possible ovarian cancer.

A woman's ovarian fibroma caused high testosterone levels, which normalized after surgery.

Minoxidil helps increase hair growth and density in people with hair loss, with higher concentrations giving better results.

Female androgenic alopecia causes hair thinning in women, especially after menopause, and affects their mental well-being.

Postmenopausal women often experience hair loss on the scalp and increased facial hair, but iron supplements may not help.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

A postmenopausal woman's high testosterone levels and symptoms improved after removing a tumor from her ovary.

A postmenopausal woman's increased male hormone levels were successfully treated with surgery.

High androgen levels in postmenopausal women may suggest an ovarian tumor, and removing it can improve heart and metabolic health.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

Doctors should check for serious tumor causes of high androgen levels in postmenopausal women and more research is needed on this condition.

Frontal fibrosing alopecia mainly affects postmenopausal women and may be linked to thyroid hormones.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Hormone Replacement Therapy improves skin health in postmenopausal women by boosting collagen and hydration.

Ovarian tumors should be considered when postmenopausal women show signs of virilization.

Frontal Fibrosing Alopecia mainly affects postmenopausal women and is linked to thyroid disease, hyperlipidemia, and anemia.

Hormone replacement therapy can improve skin aging in postmenopausal women.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Iron levels are linked to insulin resistance in men and postmenopausal women, but not in premenopausal women.

Frontal Fibrosing Alopecia is a hair loss condition mainly affecting postmenopausal women, with unclear causes and various clinical patterns.

Early diagnosis and surgery can improve symptoms of ovarian hyperthecosis in postmenopausal women.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting postmenopausal women, with unclear causes.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Removing both ovaries may better treat increased male hormone levels and related symptoms in postmenopausal women when hormone therapy doesn't work.

Leydig cell tumors in the ovary can cause high testosterone and male traits in postmenopausal women but are treatable with surgery.

Tinea capitis in adults, especially postmenopausal Black women, needs prompt treatment with oral antifungals to avoid scarring.

A 46-year-old man showed symptoms of a rare condition usually seen in postmenopausal women, highlighting the need for dentist-dermatologist collaboration.